and males (right) comparing all sickness attracting sickness benefit, with industrial dermatitisfor which injitry benefit is payable nesses which attract sickness benefit (Fig 2) , that is, the benefit payable for sickness absence due to nonindustrial causes. Table 1 compares the number of spells of sickness absence per 1000 men at risk in industries with persistent high rates. These are industries which often have specific risks, either as in coal mining from the general conditions of heat, damp and dust, or from exposure to specific risks from contact with dyes, chemical solvents or engineering oils. In the last ten years the rates for number of spells of absence has declined for industry as a whole but, among those industries listed, there is very little improvement or evidence of the condition being brought under control.
The situation in other countries is similar; in California, for example, analyses are made of the 'Doctor's first report of work injury'. In 1967, of 31 084 reports 14 815 (48 %) related to skin disease; allowing for the types of industry in California and the local hazard of poison oak, the causal agents ( Interpretation of these statistics must, of course, be cautious; there are many socio-economic factors which influence the amount of sickness absence. The diagnosis of industrial dermatitis is notoriously difficult and where work conditions cause an exacerbation of a nonindustrial skin disease, injury benefit is commonly awarded. However, whatever their limitations, these statistics are a useful method for monitoring both the amount of sickness from industrial disease and the progress in their control. They show a situation which is far from satisfactory. It is very much hoped that with the assistance of industry a systematic enquiry can be made on a wide scale, with the aims of validating the diagnosis where industrial injury benefit has been awarded, determining in what areas of industry these are most common, and relating the incidence to both the size of the plant and the type of industrial medical service offered.
Occupational Leukoderma from Alkyl Phenols by Professor C D Calnan FRCP (Institute ofDermatology, St John's Hospital for Diseases ofthe Skin, London WC2)
The control of skin colour is nowadays a matter of considerable medical, social and cosmetic importance. White people want to be deeply tanned, and dark people want to be white. Over the past thirty years a great deal has been learnt about the nature and control of skin colour in man and animals, and a sizeable cosmetic industry has built up around it.
Before much of the biological research began two important observations were made: in 1936 Oettel found that the hair of black cats could be made paler by the administration of hydroquinone, and in 1939 Oliver et al. published a report of white patches of skin on the hands observed in American negro, white and Mexican workers wearing a certain brand of 'acid cured' gloves in tanneries and other industries. They traced the cause to monobenzyl ether of hydroquinone used as an antioxidant in the rubber. Subsequently many cases of white patches of skin have been described from contact with a wide variety of rubber articles such as dress shields, brassieres, contraceptives and so on. This has never been as frequent a problem in Britain as in the United States, perhaps because of the much smaller negro population, or because of a less frequent use of hydroquinone compounds in rubber.
The problem was recently brought to my attention again when a doctor told me of a number of men using rubber adhesives who had developed white patches (leukoderma or vitiligo) on the skin of their hands and elsewhere. He had already enquired about the possible presence of hydroquinone derivatives in the rubber adhesive and had been assured that they were not present. However, when I asked if alkyl phenols could be present, the answer was yes.
The automobile industry now uses very large quantities of rubber adhesives containing appreciable amounts of an alkyl-phenol-formaldehyde resin; it is used to obtain rapid adhesion, essential to the cost-conscious moving belt production of modern cars. This type of adhesive is used in much of the internal trimming of a car, as well as in seat manufacture and rubber seals.
Neoprene adhesives containing paratertiary butyl phenol formaldehyde resin have been widely used in the leather industry as well, including manufacture and repair of boots and shoes, especially at the time of the stiletto heel, when rapid and secure adhesion of leather or other material was required to cover the thin rounded heel. Its use was extended to ordinary repairs by cobblers. Soon afterwards many cases of allergic dermatitis in boot and shoe operatives were seen, and the cause traced to contact allergy, with positive patch tests to the resin and the free phenol (Malten 1958 , Calnan & Harman 1958 . Cases of dermatitis of the feet from this source in shoes and of the wrists from watchbands have also occurred (de Vries 1964 , Foussereau et al. 1968 ). Originally the free paratertiary butyl phenol, present in excess, was considered to be the primary and more active sensitizer, but now the adhesives appear to contain less free phenol and the resin alone appears capable of sensitizing the skin. So far, however, there have been no reports of depigmentation in boot and shoe operatives, but this may have been due to a lack of medical awareness. In a recent review of occupational leukoderma from paratertiary butyl phenol and its homologues, Malten et al. (1971) stated that neither they nor other investigators of dermatitis from the resin had observed or commented on depigmentation.
Alkyl phenols are used on a large scale in industry for varnishes, lacquers, antioxidants, germicides, de-emulsifiers, oil additives, plasticizers, insecticides, deodorants, printing inks and adhesives. They are made from phenol and isobutene, isoactene or isononene. After the alkylating process the end products are separated by vacuum distillation.
Japanese production of paratertiary butyl and octyl phenols began about 1960. Within a year some of the production workers developed white patches on their skin (Okumura & Shirai 1962) . The problem was apparently caused by lack of adequate ventilation and was solved successfully by removing side Walls to provide an 'open plant' and later by rehousing the process in a better ventilated plant.
At about the same time production of alkyl phenols in Russia had also been followed by depigmentation of skin among the operatives (Chumakov et al. 1962) . Nearly half of those exposed were affected. The high concentrations of phenol and formaldehyde in the factory atmosphere made the Russian investigators suspect that the effect was produced by inhalation of a toxic chemical.
Then in 1965 Malten in Holland saw two men in one day complaining of white patches of skin; they both worked on the production of alkyl phenols at one factory (Malten et al. 1971) . He was unaware of the Russian and Japanese experience, but thought the event more than a coincidence. Later other men were affected. Some of them complained of shortness of breath or wheezing at night; symptoms which soon cleared up when they were changed to other work. Improvements to the ventilation system were not effective in general. Inhalation or ingestion of the phenol is suggested by the fact that affected workers develop symmetrical leukodermic patches on areas of the trunk or covered skin.
The Russian, Japanese and Dutch physicians all carried out experimental work in animals and were able to show that paratertiary butyl phenol would produce depigmentation of skin and hair in guinea-pigs, mice, cats and rabbits. The phenol could be applied to the skin surface, injected into the skin or fed to the animals (Itoh et al. 1968 ).
In the past two years other reports from totally different fields have confirmed the importance of this hazard from phenols. Kahn (1970) investigated a group of workers in two hospitals who were cleaning walls and floors with butyl and amyl phenols, orthophenyl phenol and orthobenzylparachlorphenol. The symptoms appeared about six months after commencing usage. Patch tests were positive. Gellin et al. (1970) encountered 4 similar patients in a group of 75 tappet assembly workers who were exposed to an oil containing parater-tiary butyl catechol as an anticorrosive agent, at a concentration of only 0.005 %. Three of them had positive patch tests.
One must now enquire as to the possible mechanism of action of the alkyl phenols. When Oliver et al. (1939) described depigmentation from monobenzyl ether of hydroquinone, they showed that most of the affected men had become allergic to it, with positive patch tests. However, most of the men with leukoderma from the phenolic compound had negative patch tests. It would appear that the effects of contact sensitization and depigmentation have separate mechanisms but may be combined; and that the hydroquinone ether is a more potent sensitizer than the alkyl phenol.
Most of the work on the pathogenesis of the leukoderma has taken place in the last five years. Brun (1967) used monoethyl ether ofhydroquinone (13%) and could regularly produce depigmentation in guinea-pigs. After four days there was no pigment in the melanocytes but they were dopa positive; after twenty-one days they were dopa negative but could still produce some repigmentation; after thirty-five days' application there was no recovery. The effect appears to be a toxic one rather than simple enzyme blockage. Using the same type of animal model Bleehen et al. (1968) showed that a large number of catechols, hydroquinones, phenol compounds and mercaptoamines had the same effect. The most potent was 4-isopropyl catechol. Many of these substances are also capable of producing an allergic contact dermatitis. The chemical requirement for depigmenting activity is a hydroxyl group in the 4 position and a non-polar side group in the 1 position of the organic ring as shown below (Riley 1969) .
How do the phenolic compounds produce depigmentation? Using labelled 4-hydroxyanisole, Riley (1970) showed that it was selectively incorporated into melanocytes grown in tissue culture. It probably reacts with the tyrosinase in the melanosomes and then forms a secondary product which diffuses into the cytoplasm and kills the cell, since the effect can be reduced or even prevented by tyrosinase inhibitors. In vitro testing of toxicity presents problems, as does animal testing, in respect of the extrapolation of data to man, but it has advantages in the solution of certain problems over conventional animal testing techniques. Nevertheless the true value of 'tissue culture' lies in complementing such animal testing and human 'in use' experience.
The techniques may include organ cultures, primary cell culture or permanent cell strain culture and the viability or activity of cultured cells may be assessed in many ways. Direct observation of growth may be qualitative and quantitative as by 'stickiness' ofcells or by estimation of the number of cells. Other methods include the study of metabolites (e.g. by estimation of the pH of supernatant fluid), the measurement of respiration, the estimation of the DNA content of the culture, and quantitative histochemistry.
These techniques have been used to study and compare the toxicology of specific enzyme systems, the toxicity ofchemically related compounds and materials used for tissue implants or transfusion apparatus, the carcinogenicity of materials, the development of cellular resistance to chemicals and atmospheric pollutants. The study of phototoxic reactions is practicable by these techniques but it has not been found possible to induce sensitization phenomena in isolated culture systems'.
It is essential that the material under test should be in solution in the culture medium and this presents problems with relatively insoluble materials such as essential oils. However, the very high sensitivity of culture systems is here of advan-'A new in vitro method of studying cutaneous allergy by tissue culture techniques was described in May 1972 by M W Greaves & S Yamamoto at a joint meeting of the Society for Investigative Dermatology and the European Society for Dermatological Research, held in Amsterdam.
